(Q36597012)

English

Phase III trial to evaluate the efficacy of maintaining hemoglobin levels above 12.0 g/dL with erythropoietin vs above 10.0 g/dL without erythropoietin in anemic patients receiving concurrent radiation and cisplatin for cervical cancer

scientific article published on 26 November 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Phase III trial to evaluate the efficacy of maintaining hemoglobin levels above 12.0 g/dL with erythropoietin vs above 10.0 g/dL without erythropoietin in anemic patients receiving concurrent radiation and cisplatin for cervical cancer (English)

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

phase III clinical trial

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

cervix uterine cancer

1 reference

based on heuristic

inferred from title

author name string

Gillian Thomas

1

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Shamshad Ali

2

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Frank J P Hoebers

3

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Kathleen M Darcy

4

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

William H Rodgers

5

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Malti Patel

6

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Ovardia Abulafia

7

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Joseph A Lucci

8

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Adrian C Begg

9

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

language of work or name

0 references

publication date

26 November 2007

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Gynecologic Oncology

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

108

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

2

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

317-325

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Cisplatin chemotherapy (without erythropoietin) and risk of life-threatening thromboembolic events in carcinoma of the uterine cervix: the tip of the iceberg? A review of the literature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2350198

9 September 2017

Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2350198

9 September 2017

Thromboembolic events in patients treated with definitive chemotherapy and radiation therapy for invasive cervical cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2350198

9 September 2017

Association of hemoglobin level with survival in cervical carcinoma patients treated with concurrent cisplatin and radiotherapy: a Gynecologic Oncology Group Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2350198

9 September 2017

The logrank test

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2350198

9 September 2017

Hypoxia and hypoxia inducible factors (HIF) as important regulators of tumor physiology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2350198

9 September 2017

Relationship between the exposure to cisplatin, DNA-adduct formation in leucocytes and tumour response in patients with solid tumours

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2350198

9 September 2017

Effect of Induced Host Anaemia on the Viability and Radiosensitivity of Murine Malignant Cells in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2350198

9 September 2017

Quantitation of cis-diamminedichloroplatinum II (cisplatin)-DNA-intrastrand adducts in testicular and ovarian cancer patients receiving cisplatin chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2350198

9 September 2017

Platinum-DNA adducts in leukocyte DNA correlate with disease response in ovarian cancer patients receiving platinum-based chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2350198

9 September 2017

Definitive evidence for hypoxic cells influencing cure in cancer therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2350198

9 September 2017

Platinum-DNA adducts assayed in leukocytes of patients with germ cell tumors measured by atomic absorbance spectrometry and enzyme-linked immunosorbent assay

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2350198

30 September 2017

Anemia: a problem or an opportunity in radiotherapy?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2350198

30 September 2017

Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2350198

28 June 2018

Exact logistic regression: theory and examples

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2350198

28 June 2018

Drug-induced DNA modification in buccal cells of cancer patients receiving carboplatin and cisplatin combination chemotherapy, as determined by an immunocytochemical method: interindividual variation and correlation with disease response.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2350198

28 June 2018

Tumor hypoxia is independent of hemoglobin and prognostic for loco-regional tumor control after primary radiotherapy in advanced head and neck cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2350198

20 September 2018

Increased incidence of symptomatic venous thrombosis in patients with cervical carcinoma treated with concurrent chemotherapy, radiation, and erythropoietin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2350198

20 September 2018

Anemia in cervical cancers: impact on survival, patterns of relapse, and association with hypoxia and angiogenesis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2350198

20 September 2018

Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2350198

20 September 2018

Sample-size formula for the proportional-hazards regression model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2350198

20 September 2018

Improved treatment for cervical cancer--concurrent chemotherapy and radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.011

7 January 2021

The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.011

7 January 2021

The Effect of Alterations in Haematocrit on Tumour Sensitivity to X-rays

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.011

7 January 2021

The effect of anaemia on the fraction of hypoxic cells in an experimental tumour

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.011

7 January 2021

Low hemoglobin is associated with increased serum levels of vascular endothelial growth factor (VEGF) in cancer patients. Does anemia stimulate angiogenesis?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.011

7 January 2021

Tumor hypoxia, p53, and prognosis in cervical cancers

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.011

7 January 2021

DNA-adduct levels as a predictor of outcome for NSCLC patients receiving daily cisplatin and radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.011

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.011

7 January 2021

A Survey of Exact Inference for Contingency Tables

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.011

7 January 2021

Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.011

7 January 2021

Weighing the hazards of erythropoiesis stimulation in patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.011

7 January 2021

What is the risk of bowel perforation associated with bevacizumab therapy in ovarian cancer?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.011

7 January 2021

Relationship between platinum-DNA adducts in leukocytes of patients with advanced germ cell cancer and survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/18037478

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix

1 reference

https://pubmed.ncbi.nlm.nih.gov/18037478

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship between patient response in ovarian and breast cancer and platinum drug-DNA adduct formation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18037478

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Platinum-DNA adduct in leukocyte DNA of a cohort of 49 patients with 24 different types of malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/18037478

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inductively coupled plasma mass spectroscopy quantitation of platinum-DNA adducts in peripheral blood leukocytes of patients receiving cisplatin- or carboplatin-based chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18037478

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.YGYNO.2007.10.011

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36597012&oldid=2043370671"